Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Visalli

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Diabetologia|October 1, 1987
Reduced protection against hepatitis B virus following vaccination in patients with type 1 (insulin-dependent) diabetesP Pozzilli, P Arduini, N Visalli, et al.
Diabetes Care|August 1, 1994
Combination of nicotinamide and steroid versus nicotinamide in recent-onset IDDM. The IMDIAB II StudyP Pozzilli, N Visalli, M L Boccuni, et al.
Diabetologia|July 1, 1995
Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study)P Pozzilli, N Visalli, A Signore, et al.
Diabete & Metabolisme|February 1, 1995
Adjuvant therapy in recent onset type 1 diabetes at diagnosis and insulin requirement after 2 yearsP Pozzilli, N Visalli, R Buzzetti, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1994
Randomized trial comparing nicotinamide and nicotinamide plus cyclosporin in recent onset insulin-dependent diabetes (IMDIAB 1). The IMDIAB Study GroupP Pozzilli, N Visalli, M L Boccuni, et al.
Diabetes Care|January 1, 1996
A 5-year (1989-1993) prospective study of the incidence of IDDM in Rome and the Lazio region in the age-group 0-14 yearsL Sebastiani, N Visalli, E Adorisio, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|December 19, 2007
Age at diagnosis of type 1 diabetes and the effect of immunomodulatory therapies on residual beta cell functionD Pitocco, E DiStasio, A Crinò, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 1, 2006
Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetesA Picardi, N Visalli, A Lauria, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 31, 2007
Length of gestation and gender are associated with HLA genotypes at risk for Type 1 diabetes (Italian DIABFIN 3)M Locatelli, R Buzzetti, A Galgani, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|October 5, 2005
A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitusA Crinó, R Schiaffini, P Ciampalini, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Diabetologia|October 1, 1987
Reduced protection against hepatitis B virus following vaccination in patients with type 1 (insulin-dependent) diabetesP Pozzilli, P Arduini, N Visalli, et al.
Diabetes Care|August 1, 1994
Combination of nicotinamide and steroid versus nicotinamide in recent-onset IDDM. The IMDIAB II StudyP Pozzilli, N Visalli, M L Boccuni, et al.
Diabetologia|July 1, 1995
Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study)P Pozzilli, N Visalli, A Signore, et al.
Diabete & Metabolisme|February 1, 1995
Adjuvant therapy in recent onset type 1 diabetes at diagnosis and insulin requirement after 2 yearsP Pozzilli, N Visalli, R Buzzetti, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1994
Randomized trial comparing nicotinamide and nicotinamide plus cyclosporin in recent onset insulin-dependent diabetes (IMDIAB 1). The IMDIAB Study GroupP Pozzilli, N Visalli, M L Boccuni, et al.
Diabetes Care|January 1, 1996
A 5-year (1989-1993) prospective study of the incidence of IDDM in Rome and the Lazio region in the age-group 0-14 yearsL Sebastiani, N Visalli, E Adorisio, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|December 19, 2007
Age at diagnosis of type 1 diabetes and the effect of immunomodulatory therapies on residual beta cell functionD Pitocco, E DiStasio, A Crinò, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 1, 2006
Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetesA Picardi, N Visalli, A Lauria, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 31, 2007
Length of gestation and gender are associated with HLA genotypes at risk for Type 1 diabetes (Italian DIABFIN 3)M Locatelli, R Buzzetti, A Galgani, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|October 5, 2005
A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitusA Crinó, R Schiaffini, P Ciampalini, et al.
Pageof 5